Wuxi, China

Xiaoying Wang

This inventor holds 3 USPTO granted patents. Top assignee: Jiangnan University. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoying Wang. Retrieved from https://idiyas.com/inventor/xiaoying-wang-asplybij

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 8.2

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Xiaoying Wang in Medical Biology

Introduction

Xiaoying Wang is a notable inventor based in Wuxi, China. He has made significant contributions to the field of medical biology, particularly through his innovative research and development of therapeutic agents.

Latest Patents

Xiaoying Wang holds a patent for a fatty acid synthase inhibitor and its applications. This invention is crucial as it can significantly inhibit the activity of fatty acid synthase without affecting normal expression. The inhibitor adjusts the ratio of fatty acids in cells and demonstrates a good tumor proliferation inhibitory effect. It can arrest the growth cycle of tumor cells in the interphase, prevent tumor cell division, inhibit tumor cell proliferation, and promote tumor cell apoptosis. This invention has important clinical application prospects for treating tumors and metabolism-related diseases.

Career Highlights

Xiaoying Wang is affiliated with Jiangnan University, where he continues to advance his research in medical biology. His work has garnered attention for its potential impact on cancer treatment and metabolic disorders.

Collaborations

Xiaoying Wang collaborates with esteemed colleagues, including Yongquan Chen and Hongyan Qu, who contribute to his research endeavors.

Conclusion

Xiaoying Wang's innovative work in developing a fatty acid synthase inhibitor showcases his commitment to advancing medical biology. His contributions hold promise for significant advancements in cancer treatment and metabolic health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…